The Global Dental Partnering 2010-2016: Deal trends, players and financialsreport provides comprehensive understanding and unprecedented access to the dental partnering deals and agreements entered into by the worlds leading healthcare companies Global Dental Partnering 2010 to 2016 provides the full collection of Dental disease deals signed between the worlds pharmaceutical and biotechnology companies since 2010.
Trends in Dental partnering deals
Financial deal terms for headline, upfront and royalty by stage of development
Dental partnering agreement structure
Dental partnering contract documents
Top Dental deals by value
Most active Dental dealmakers
Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensors product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.
The report takes readers through the comprehensive Dental disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Dental deals.
The report presents financial deal terms values for Dental deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.
The initial chapters of this report provide an orientation of Dental dealmaking trends.
Chapter 1 provides an introduction to the report.
Chapter 2 provides an overview of the trends in Dental dealmaking since 2010 covering trends by year, deal type, stage of development, technology type and therapeutic indication.
Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.
Chapter 4 provides a review of the leading Dental deals since 2010. Deals are listed by headline value. The chapter includes the top 25 most active Dental dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.
Chapter 5 provides comprehensive access to Dental deals since 2010 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.
Chapter 6 provides a comprehensive directory of all Dental partnering deals by specific Dental target announced since 2010. The chapter is organized by specific Dental therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
In addition, a comprehensive appendix is provided with each report of all Dental partnering deals signed and announced since 2010. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
The report also includes numerous tables and figures that illustrate the trends and activities in Dental partnering and dealmaking since 2010.
In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Dental technologies and products.
Global Dental Partnering 2010 to 2016 is intended to provide the reader with an in-depth understanding and access to Dental trends and structure of deals entered into by leading companies worldwide.
Global Dental Partnering 2010 to 2016 includes:
Trends in Dental dealmaking in the biopharma industry since 2010
Analysis of Dental deal structure
Access to headline, upfront, milestone and royalty data
Access to hundreds of Dental deal contract documents
Comprehensive access to over 3500 Dental deal records
The leading Dental deals by value since 2010
Most active Dental dealmakers since 2010
The report includes deals for the following indications: Dental caries, Mouth ulcer, Mucositis, Periodontal disease, Oral health, Xerostomia, plus other dental indications.
In Global Dental Partnering 2010 to 2016, available deals and contracts are listed by:
Upfront payment value
Royalty rate value
Stage of development at signing
Deal component type
Specific therapy indication
Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
The Global Dental Partnering 2010-2016 report provides comprehensive access to available deals and contract documents for over 200 dental deals. Analyzing actual contract agreements allows assessment of the following:
What are the precise rights granted or optioned?
What is actually granted by the agreement to the partner company?
What exclusivity is granted?
What is the payment structure for the deal?
How are the sales and payments audited?
What is the deal term?
How are the key terms of the agreement defined?
How are IPRs handled and owned?
Who is responsible for commercialization?
Who is responsible for development, supply, and manufacture?
How is confidentiality and publication managed?
How are disputes to be resolved?
Under what conditions can the deal be terminated?
What happens when there is a change of ownership?
What sublicensing and subcontracting provisions have been agreed?
Which boilerplate clauses does the company insist upon?
Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
Which jurisdiction does the company insist upon for agreement law?
Chapter 1 Introduction
Chapter 2 Trends in Dermatology dealmaking
2.2. Dermatology partnering over the years
2.3. Dermatology partnering by deal type
2.4. Dermatology partnering by industry sector
2.5. Dermatology partnering by stage of development
2.6. Dermatology partnering by technology type
2.7. Dermatology partnering by therapeutic indication
Chapter 3 Financial deal terms for Dermatology partnering
3.2. Disclosed financials terms for Dermatology partnering
3.3. Dermatology partnering headline values
3.4. Dermatology deal upfront payments
3.5. Dermatology deal milestone payments
3.6. Dermatology royalty rates
Chapter 4 Leading Dermatology deals and dealmakers
4.2. Most active in Dermatology partnering
4.3. List of most active dealmakers in Dermatology
4.4. Top Dermatology deals by value
Chapter 5 Dermatology contract document directory
5.2. Dermatology partnering deals where contract document available
Chapter 6 Dermatology dealmaking by therapeutic target
6.2. Deals by Dermatology therapeutic target
Appendix 1 Directory of Dermatology deals by company A-Z 2010 to 2016
Appendix 2 Directory of Dermatology deals by deal type 2010 to 2016
Appendix 3 Directory of Dermatology deals by stage of development 2010 to 2016
Appendix 4 Directory of Dermatology deals by technology type 2010 to 2016
List Of Figures
Figure 1: Dermatology partnering since 2010
Figure 2: Dermatology partnering by deal type since 2010
Figure 3: Dermatology partnering by industry sector since 2010
Figure 4: Dermatology partnering by stage of development since 2010
Figure 5: Dermatology partnering by technology type since 2010
Figure 6: Dermatology partnering by indication since 2010
Figure 7: Dermatology deals with a headline value
Figure 8: Dermatology deals with upfront payment values
Figure 9: Dermatology deals with milestone payment
Figure 10: Dermatology deals with royalty rates
Figure 11: Active Dermatology dealmaking activity 2010 to 2016
Figure 12: Top Dermatology deals by value since 2010
Notes:Production, means the output of - linolenic acid (GLA)Revenue, means the sales value of - linolenic acid (GLA)This report studies - linolenic acid (GLA) in Global market, especially in North
Notes:Production, means the output of -AmylaseRevenue, means the sales value of -AmylaseThis report studies -Amylase in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with
Notes:Production, means the output of Zirconium Oxide Flap DiscRevenue, means the sales value of Zirconium Oxide Flap DiscThis report studies Zirconium Oxide Flap Disc in Global market, especially in North
Notes:Sales, means the sales volume of Dermatology Diagnostic and Therapeutic DevicesRevenue, means the sales value of Dermatology Diagnostic and Therapeutic DevicesThis report studies sales (consumption) of Dermatology Diagnostic and Therapeutic
Notes:Production, means the output of Dermatology DrugRevenue, means the sales value of Dermatology DrugThis report studies Dermatology Drug in Global market, especially in North America, China, Europe, Southeast Asia, Japan
Notes:Production, means the output of Dermatology DevicesRevenue, means the sales value of Dermatology DevicesThis report studies Dermatology Devices in Global market, especially in North America, China, Europe, Southeast Asia, Japan